Wave Life Sciences, Inc.
WVE · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Ra Capital Management, L.P.: Form 4
Insider disclosure · Filed · Report period 05 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001631574 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- WVE on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 733 Concord Avenue, Cambridge, MA, 02138
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Wave Life Sciences Ltd. (to 30 Jul 2026), Wave Life Sciences LTD. (to 30 Jul 2026), WAVE Life Sciences Ltd. (to 30 Jul 2026), Wave Life Sciences Pte Ltd (to 02 Nov 2015)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields